PANW Q3 2026 Earnings Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PANW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PANW
Wall Street analysts forecast PANW stock price to fall
34 Analyst Rating
28 Buy
5 Hold
1 Sell
Strong Buy
Current: 280.430
Low
157.00
Averages
232.49
High
265.00
Current: 280.430
Low
157.00
Averages
232.49
High
265.00
About PANW
Palo Alto Networks, Inc. is a global artificial intelligence (AI) cybersecurity company, with a comprehensive portfolio of cybersecurity solutions and platforms across network, cloud, security operations, AI and Identity. Its network security platform includes Secure Access Service Edge (SASE), Next-Generation Firewalls, Cloud Delivered Security Services (CDSS), Prisma AIRS, and Strata Cloud Manager (SCM). It delivers security operations capabilities that unifies standalone Security Information and Event Management (SIEM) tools, endpoint security, security automation, cloud detection and response (CDR), as well as attack surface management (ASM) capabilities on its Cortex platform. It delivers comprehensive security across the cloud application development lifecycle through Cortex Cloud. Its Unit 42 brings together expertise across threat research, incident response, and security consulting to deliver intelligence-driven, response-ready outcomes that help customers reduce cyber risk.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Reaction: CrowdStrike, Broadcom, and Palo Alto Networks all reported solid quarterly results and forward guidance, yet the market's negative response indicates a disconnect between high investor expectations and actual outcomes, leading to stock declines.
- Price Fluctuations: Palo Alto Networks has seen a three-day losing streak, although it remains up 9.3% since May 27, while CrowdStrike is up 7.8% and Broadcom is down 1.7%, reflecting the volatility in market sentiment towards these tech stocks.
- Market Sentiment: Analysts have generally raised price targets for these companies, but the excessive enthusiasm for AI-related stocks led to significant pre-earnings price increases, resulting in adjustments post-earnings that highlight the fragility of market sentiment.
- Investment Strategy: Despite short-term price fluctuations, Jim Cramer maintains a bullish outlook on all three companies, advising investors to buy at the right time, emphasizing that their fundamentals remain strong and that increased market supply may exert short-term price pressure.
See More
- Strategic Collaboration: Alnylam Pharmaceuticals has entered into a strategic AI partnership with Inceptive Nucleics valued at up to $2 billion, aiming to leverage Inceptive's generative AI models to accelerate the discovery of RNA interference therapeutics, thereby enhancing its competitive edge in the biopharmaceutical sector.
- Market Rebound: Blackstone's shares rose 8% despite the firm limiting withdrawals from its Private Credit fund, indicating investor confidence as the stock is poised to end a three-day losing streak, reflecting a positive sentiment towards asset management firms.
- Stock Volatility: Broadcom's shares tumbled nearly 15% after reporting second-quarter revenue of $22.19 billion, falling short of the $22.27 billion expected by analysts, although CEO Hock Tan reiterated the company's fiscal year 2027 revenue guidance for AI chips to exceed $100 billion, raising concerns about future growth prospects.
- Healthcare Outlook: UnitedHealth's stock climbed 5% following an upgrade from Bank of America from neutral to buy, citing improving medical cost trends and supportive near-term data points that are expected to favorably impact second-quarter earnings, reflecting optimism in the health insurance sector.
See More

- Government Investment Accelerates Quantum Computing: The U.S. Department of Commerce signed letters of intent with nine companies to provide approximately $2 billion to support the quantum computing sector, indicating that quantum technology has become a national strategy and prompting enterprises to expedite their post-quantum cybersecurity preparations.
- Business Model Transformation: Quantum Secure Encryption Corp has entered the commercial deployment phase, currently serving 262 customer accounts, with significant growth expected in 2026, reflecting the urgent market demand for post-quantum security solutions.
- Enhanced Technical Leadership: The appointment of Michael Massing as Chief Technology Officer, with over 30 years of experience in cybersecurity and cryptography, is expected to drive the expansion of the company's technology platform, enhancing its market competitiveness to meet the growing demand for post-quantum security.
- Diversified Revenue Model: The company generates revenue through SaaS, enterprise deployments, and usage-based secure storage services, indicating strong growth potential in the post-quantum security market, particularly within government and regulated industries.
See More

- Government Investment Acceleration: The U.S. Department of Commerce signed letters of intent with nine companies to provide approximately $2 billion to support the quantum computing sector, indicating that quantum computing has become a core part of national technology strategy, which QSE believes accelerates the need for post-quantum cybersecurity.
- Customer Base Expansion: QSE currently serves 262 customer accounts and is entering a phase of commercial scaling, with growing demand from enterprise, government, and regulated industries expected to significantly boost revenue and market share.
- Mature Technology Platform: QSE has launched a fully available post-quantum cybersecurity platform encompassing Assess, Protect, and Control Access functions, aimed at helping organizations address future quantum threats while enhancing existing security infrastructure.
- Executive Appointment: QSE appointed Michael Massing as Chief Technology Officer, bringing over 30 years of experience in cybersecurity and cryptography, which will drive the company's technological expansion and market penetration in the post-quantum security space.
See More

- Palo Alto Networks Performance: Palo Alto Networks (PANW) reported third-quarter adjusted earnings and revenue exceeding analyst expectations, with a 31% revenue growth to $3 billion, although its stock is pressured by valuation and dilution concerns.
- CrowdStrike's Decline: Despite CrowdStrike (CRWD) posting strong first-quarter results, its stock fell as investors had set high expectations for annual recurring revenue growth, indicating market caution regarding future growth.
- SentinelOne Revenue Growth: SentinelOne (S) saw a 21% revenue increase, but its shares tumbled as investors focused on its outlook and workforce reductions, reflecting concerns about the company's future trajectory.
- Fortinet Stock Surge: Fortinet (FTNT) shares surged after posting first-quarter earnings and guidance above estimates, driven by a 31% jump in billings, showcasing the success of technology upgrades and customer expansion.
See More
- Tech Stock Decline: Broadcom (AVGO) shares plummeted over 15% after its AI revenue forecast fell short, marking it as the largest decliner in the Nasdaq 100, which reflects growing concerns about the tech sector and may dampen investor confidence.
- Weak Employment Data: Initial jobless claims in the US rose by 13,000 to 225,000, reaching a 3.75-month high, indicating a weakening labor market that could lead to downward revisions in growth expectations.
- Healthcare Stocks Strong: UnitedHealth Group (UNH) surged over 6%, leading gains in the S&P 500, after Bank of America upgraded its rating from neutral to buy with a price target of $450, showcasing resilience in the healthcare sector.
- International Market Volatility: European markets showed mixed results, with Eurozone April retail sales falling 0.4% month-over-month, worse than the expected 0.3%, indicating weak consumer spending that could pressure future economic growth.
See More








